Related Experiment Video
Updated: Jun 6, 2025

07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.1K
Subtype-Specific Detection in Stage Ia Breast Cancer: Integrating Raman Spectroscopy, Machine Learning, and Liquid
Kevin Saruni Tipatet1,2, Katie Hanna3, Liam Davison-Gates1
1Institute for BioEngineering, School of Engineering, University of Edinburgh, Edinburgh, UK.
Journal of Biophotonics
|November 26, 2024
Summary
Raman spectroscopy and machine learning detect and subtype early breast cancer from blood plasma. This non-invasive method achieves 90% sensitivity and 95% specificity for four major subtypes at stage Ia.
Area of Science:
- Biomedical engineering
- Medical diagnostics
- Spectroscopy
Background:
- Early breast cancer detection and subtyping are crucial for effective treatment.
- Current diagnostic methods can be invasive or lack specificity for early stages.
- Vibrational spectroscopy offers a label-free approach to analyze biological samples.
Purpose of the Study:
- To integrate Raman spectroscopy (RS) with machine learning for early breast cancer detection.
- To classify the four major breast cancer subtypes using blood plasma.
- To establish a non-invasive, personalized diagnostic tool for early-stage breast cancer.
Main Methods:
- Collected blood plasma samples from breast cancer patients and healthy controls.
- Performed Raman spectroscopy to acquire detailed spectral data.
- Utilized machine learning algorithms for spectral pattern analysis and classification.
Main Results:
- Identified significant spectral patterns in plasma associated with breast cancer biomarkers.
- Achieved high classification performance for the four major breast cancer subtypes at stage Ia.
- Reported average sensitivity of 90%, specificity of 95%, and cross-validated AUC of 0.98.
Conclusions:
- Raman spectroscopy combined with machine learning shows significant potential for early breast cancer detection and subtyping.
- This integrated approach offers a non-invasive, personalized method for cancer diagnostics and monitoring.
- This study represents a novel application of RS and machine learning for classifying early-stage breast cancer subtypes.

